Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.
Teicoplanin was evaluated in 47 patients with severe infections, including 14 patients with bone infections, 11 patients with soft-tissue infections, 7 patients with endocarditis, 5 patients with pneumonia, 3 patients with septic thrombophlebitis, 3 patients with septicemia of unknown origin, and 4...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180363/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2942100/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.1.52 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|